Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

The MIRA technique improves cellulite treatment and skin quality better than standard methods.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

The MIRA technique improves cellulite treatment results and patient satisfaction.

Vitex negundo may help treat PCOD, but more human studies are needed.

Early identification and personalized treatment of skin issues in PCOS are crucial for better outcomes.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

Improving diet and lifestyle can help manage skin conditions linked to insulin resistance and inflammation.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

Androgenetic alopecia patients have a higher risk of metabolic syndrome.

IL10_ApoEVs improve skin healing and reduce scarring.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Men with hair loss may have more body fat and different blood characteristics.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Free long-chain fatty acids can stimulate hair growth in mice.

Melatonin improves cashmere quality and yield in goats by enhancing hair follicle development.

Rhamnose may help hair growth and pigmentation, making it a potential treatment for hair loss.

Women with PCOS have distinct retinal changes compared to healthy women.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

A 5% concentration of Dorema aucheri extract significantly improves diabetic wound healing.

Young males with severe early-onset hair loss may have a higher risk of metabolic syndrome.

Recognizing rare causes of MASLD is crucial for effective treatment and preventing complications.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Hormonal imbalances are important in the development of male pattern baldness.